Mahama Called for Boost to African Drug Production
Former leader John Dramani Mahama urged for greater investment to reduce reliance on pharmaceutical imports.
Updated on Oct. 3, 2026 in Manufacturing
Live Poll
Should nations prioritize domestic manufacturing of essential products to improve long-term economic security?
John Dramani Mahama has called for increased investment in local African pharmaceutical manufacturing to address a heavy reliance on imports. The move aims to mitigate risks associated with global supply chain disruptions and foreign exchange outflows.
Why it matters
Africa currently imports over 70 percent of its pharmaceuticals and nearly 99 percent of its vaccines, leaving the continent vulnerable to global shocks. Expanding local production is viewed as a critical step toward economic independence and healthcare security for a population projected to reach 2.5 billion by 2050.
The Africa CDC pooled tender for maternal and child health products achieved price reductions between 30 and 90 percent. Local manufacturers successfully secured 50 percent of the product lines featured in the tender.
The players
John Dramani Mahama
John Dramani Mahama is a prominent African political leader who previously served as the President of Ghana.
Africa CDC
The Africa Centres for Disease Control and Prevention is a specialized health agency of the African Union responsible for public health initiatives.
The details
Addressing an audience in Alamein, Egypt, John Dramani Mahama highlighted that the African Continental Free Trade Area provides a necessary framework for manufacturers to serve a unified continental market. By coordinating demand through mechanisms like the Africa CDC pooled tender, nations can reduce costs while incentivizing local industrial growth.
Timeline
2050 is the year Africa's population is projected to reach 2.5 billion.
Market Landscape
This push for pharmaceutical independence mirrors the broader goals of the African Continental Free Trade Area, which seeks to integrate regional markets. By shifting away from import reliance, African nations aim to challenge established global supply chains and increase intra-continental trade.
The transition toward local manufacturing could lead to more stable pricing and consistent availability of essential medicines for citizens across the continent. Consumers may benefit from lower costs as pooled procurement initiatives continue to reduce the expense of maternal and child health products.
The takeaway
Reducing import dependence is a strategic necessity to protect healthcare access for Africa's rapidly growing population. Investments in local capacity allow nations to capture economic value while building resilience against future global supply chain volatility.
Further reading
For more information on the evolving industrial sector, visit our Manufacturing section.
Live Poll
Should nations prioritize domestic manufacturing of essential products to improve long-term economic security?
